Richard D. Batson is the executive director and co-founder of Neurevolution Medicine, LLC. His clinical practice focuses on traumatic brain injury evaluation and rehabilitation with a specialization in traumatic brain injury-related pituitary dysfunction. In addition, he has an interest the diagnosis and treatment of testosterone deficiency secondary to obesity, diabetes mellitus, as well as late-onset hypogonadism.
Dr. Batson’s postgraduate dissertation is in the area of post-traumatic hypopituitarism (PTHP), also referred to a TBI-related neuroendocrine dysfunction, or TBI-related pituitary dysfunction. PTHP is a group of endocrine disorders that evolve in some individuals following traumatic brain injury and results in select or multiple hormonal deficiencies. He works clinically with the TBI population with a focus on evaluation and treatment of PTHP. In addition, he is sought after by legal experts for consultation and testimony pertaining PTHP as well as other brain-injury related conditions and has served as a forensic medical expert in over one hundred and fifty traumatic brain injury cases. He currently manages multi-disciplinary forensic evaluations across the fields of endocrinology, neurology, neuroradiology, occupational medicine, and neuropsychology. He also works in close collaboration with specialists in the fields of sleep medicine, neuropsychiatry and neuro-optometry, particularly with respect to traumatic brain injury related sleep, psychiatric and visual disorders.
He has generated a number of publications and academic papers including on topics related to post-traumatic hypopituitarism (PTHP), selection criteria and eligibility for growth hormone replacement in patients with hypopituitarism, the management of hypogonadotropic hypogonadism in type 2 diabetes mellitus and obesity, a review of triiodothyronine (T3) therapy in hypothyroidism, the diagnosis and management of primary hyperaldosteronism, guidelines for the diagnosis and management of polycystic ovary syndrome, bidirectional and tandem actions of aldosterone and parathyroid hormone with implications for cardiovascular, bone and metabolic disease risk and prevention, and management of fragility fractures in the age male in endocrinology practice. He has also conducted literature reviews in the areas of psychotic disorders following traumatic brain injury, hypogonadotropic hypogonadism following traumatic brain injury, and a review of the cosyntropin stimulation test in secondary adrenal insufficiency diagnosis.
Most recently, he served as a content expert for a Cochrane Systematic Review on biofeedback and IBS and co-authored a chapter on the comprehensive treatment of osteoarthritis published in Metabolic Therapies in Orthopedics recently featured in the Hopkins Reader, Johns Hopkins Medicine. He is the recipient of the 2012 Natural Standard Research Collaboration Award for excellence in multidisciplinary, evidence-based research practices, healthcare communications and information. Natural Standard is an international research collaboration that systematically reviews scientific evidence on complementary and alternative medicine (CAM) and together with the faculty of Harvard Medical School, Natural Standard provides consumer information on CAM for Harvard Health Publications.
In addition, he is an adjunct peer-reviewer for Biofactors, Cardiovascular Endocrinology & Metabolism, Current Medical Research & Opinion, Endocrine Practice, Endocrine Reviews, European Journal of Endocrinology, Growth Hormone & IGF-1 Research, Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Medicine, Journal of the Endocrine Society, and Pituitary and has also been an invited peer-reviewer for the Journal of Alzheimer's Disease
He holds a Master of Science in Clinical Endocrinology with distinction and is a Diplomate in Clinical Endocrinology with distinction. His endocrine clinical practice focuses on evaluating and managing select endocrine conditions including hypopituitarism, hypothyroidism, male and female hypogonadism, and polycystic ovarian syndrome, as well as screening for a variety of endocrine conditions with referral and coordinated care involving generalists and specialists in the fields of endocrinology and neuroendocrinology.
*Dr. Batson does not prescribe hormonal therapies for anti-aging , cosmetic purposes, or for athletic performance.
Dr. Karen Parker is the co-founder of Neurevolution Medicine, LLC and a licensed naturopathic physician in Washington State. She is a fellow in metabolic and integrative medicine, and an advanced fellow in functional medicine. She is also a nationally certified menopause provider by the North American Menopause Society.
Dr. Parker's practice focuses on hormonal influences on female stress resilience, mood, cognition and interpersonal relationships. She provides individualized treatments related to hormonal health, peri- and post-menopausal and age-related cognitive changes, as well as endocrine, cardio-metabolic health and weight loss.
She works in a collaborative care model which includes the disciplines of cardiology, endocrinology, gastroenterology, gynecology neuropsychology, psychiatry and sleep medicine.
For details about Dr. Parker’s integrative healthcare practice for Women please visit drkarenparker.com
Dr. Robert Turner is a board-certified neurologist who practices both adult and pediatric neurology with a subspecialty in epileptology. He is a licensed physician in Washington & South Carolina. Dr. Turner has worked with the brain injured population for over 30 years in both pediatric and adult patient populations. His seasoned experience with the brain injured population, particularly with both post-traumatic seizure disorders and with epilepsy, affords Dr. Turner unique skills and a dynamic perspective on brain injury.
Dr. Robert Turner is an associate professor of Clinical Neurology and Pediatrics & Neurology at the University of South Carolina School of Medicine & Palmetto Health Richland Children’s Hospital in Columbia, South Carolina, as well an associate clinical professor of pediatrics at the Medical University of South Carolina (MUSC). In addition, he is Community Faculty at Bon Secours Roper-St. Francis Hospital System in Charleston, South Carolina. Dr. Turner holds a Master of Science in Clinical Research in Epidemiology and Biostatistics. He has authored numerous peer-reviewed publications and contributed to multiple text books in field of clinical neurology and epilepsy. Dr. Turner has specialized training in neurophysiology, including electroencephalography (EEG), and is experienced in evaluating and treating patients with post-traumatic seizure disorders and post-traumatic epilepsy.
Dr. David Cantor is a licensed psychologist with a specialization in pediatric developmental neuropsychology. He received his masters and doctorate in psychology at the State University of New York at Stony Brook with a dissertation on quantitative electroencephalography correlates of autism. Dr. Cantor also holds a postdoctoral Master of Science in psychopharmacology from Fairleigh Dickinson University.
He is a fellow of the National Academy of Neuropsychology (NAN), was former Chair of the International Board of Quantitative Electrophysiology (IBQE), former President of the EEG and Clinical Neuroscience Society (ECNS), and President and Board of Director member of the International Societies of NeuroRegulation and Research (ISNR). He is a former faculty member of the Maryland School of Medicine where he conducted research and clinically managed QEEG and Evoked Potential findings for traumatic brain injury patients of the famed Shock Trauma Institute in Baltimore, MD.
In addition, Dr. Cantor is the recipient of a special award from the Neuro-Optometric Rehabilitative Association International for his contributions in the field of vision and behavior in patients with brain injury. Dr. Cantor has been active in clinical practice, research, teaching, and publishing for over thirty-five years. He has several awards and publications in the general fields of developmental disorders, biobehavioral sciences, and functional neurosciences and was a member of the team of experts that led to the 2012 Trial Attorney Award in a multi-case action which substantiated neurotoxicological damage due to lead exposure.
Dr. Joshua Goldenberg is an active researcher with numerous publications in high impact scientific journals such as JAMA, Annals of Internal Medicine and The Cochrane Library. He is a Research Investigator at the Bastyr University Research Institute and Visiting Research Scholar at the University of Technology Sydney. He has presented nationally and internationally on evidence-based medicine as well as probiotics and research methodology. His probiotics work has been highlighted by the BBC, The New York Times, The Seattle Times, Prevention Magazine, and Fox News. In addition, Dr. Goldenberg has worked in collaboration with Dr. Richard D. Batson to author several systematic reviews in the areas of traumatic-brain injury related hypopituitarism and traumatic brain injury related psychosis, and other healthcare research. Dr. Goldenberg and Dr. Batson were contributing authors to a 2019 Cochrane systematic review of the effects of biofeedback on irritable bowel syndrome (PMID: 31713856).
Dr. Goldenberg is faculty for the Academy of Integrative Health and Medicine’s Interprofessional Fellowship in Integrative Health and Medicine, where he teaches critical evaluation of the literature and evidence-informed practice. He is past adjunct faculty at Bastyr University, his alma mater, in which he enrolled after receiving honors and distinction in molecular biology from the University of Pennsylvania. Dr. Goldenberg works in close collaboration with Dr. Batson as part of the medico-legal research and record review team.